HCPLive Network
  • CMHC 2014
  • CHEST 2014
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Friday, October 31, 2014
By HCPLive staff
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.
Friday, October 31, 2014
By Jackie Syrop
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
Friday, October 31, 2014
By Adam Hochron
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
Friday, October 31, 2014
For women with polycystic ovary syndrome (PCOS), cinnamon supplements may improve menstrual cyclicity, according to a study published in the November issue of the American Journal of Obstetrics & Gynecology.
Friday, October 31, 2014
By Jackie Syrop
In the American Journal of Medicine, Christopher Sorli, MD, of the Billings Clinic in Montana, reviewed new developments in insulin therapy for type 2 diabetes. He explained that insulin initiation often involved basal-only therapy in conjunction with existing oral glucose-lowering drugs.
Friday, October 31, 2014
Key challenges have been identified for health professionals communicating the role of human papillomavirus in oropharyngeal squamous cell cancer, according to a study published online Oct. 28 in Head & Neck.
Friday, October 31, 2014
A putative neuroplasticity-enhancing drug, D-cycloserine, is feasible and well tolerated to facilitate a computer-assisted cognitive training (CT) program for improving tinnitus-associated cognitive deficits, according to a study published online Oct. 30 in JAMA Otolaryngology-Head & Neck Surgery.
Friday, October 31, 2014
Dentists are uniquely placed to identify patients with diabetes, and those with diabetes who are at risk for complications, according to an article published in the October issue of Clinical Diabetes.
Friday, October 31, 2014
Complication rates are similar for single-level anterior cervical discectomy and fusions, whether the procedure is performed by a neurosurgeon or orthopedic surgeon, according to a study published in the Sept. 15 issue of Spine.
Friday, October 31, 2014
By Jacquelyn Gray
For children, pain management regimens should aim for an acceptable level of pain, optimal mobilization, and minimal side effects, according to research published in Pediatric Anesthesia.
Friday, October 31, 2014
By Julia Ernst, MS
The compound AIN457 (secukinumab) has been granted a unanimous vote of support for approval from the Dermatologic and Ophthalmic Drugs Advisory Committee to the Food and Drug Administration.
Friday, October 31, 2014
By Julia Ernst, MS
Amgen has released positive top-line results from the first of two Phase III studies of ABP 501, its candidate for the treatment of moderate-to-severe plaque psoriasis that is being developed as a biosimilar to adalimumab.
Email Signup
Breaking News
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
The US Food and Drug Administration (FDA) today announced the approval of Trumenba, the first vaccine licensed in the US to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.
Governors in four states have enacted quarantines on health care workers returning from treating Ebola patients in West Africa. The US Centers for Disease Control and Prevention (CDC) says that is not necessary. In interviews with HCPLive’s Gale Scott, two physicians offered sharply different opinions on the states' quarantine policy.
Physician's Money Digest
The end of Daylight Saving Time means an “extra” hour for most Americans. And while the vast majority of people will use that extra hour to sleep, Fidelity Investments is suggesting a different idea: Use the time to focus on your finances.
Any businessperson knows taxes can make a significant difference to their company’s bottom line. And while recent tax inversions by multinational corporations have highlighted the effects of federal tax policy, local and states taxes can also play a major role determining whether a business thrives, fails, or even relocates.
Product News
Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) has been approved to treat acquired hemophilia A (acquired Factor VIII deficiency), a rare, non-inherited form of hemophilia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
The US Food and Drug Administration (FDA) has approved the use of an experimental drug to treat patients who have Ebola Virus Disease.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?